Leveraging EHR to Maintain Clinical Research Billing Compliance
Learn to set up and use the EHR to run a compliant clinical research billing program, including inpatient-stay trials, budget development and sponsor vs insurance billing.
Speaker
Mary Veazie
Clinical research finance expert · CPA
Overview
Every organization that takes part in clinical research needs a clinical research billing (CRB) program built on applicable federal and state rules. As trials grow more complex, technology such as the electronic health record (EHR) becomes central to running the program and reducing compliance risk.
This 60-minute webinar covers how to set up the EHR for clinical research billing, best practices for billing, and the downstream effects of optimizing the EHR.
You'll also look at trials that require inpatient stays, including when to bill the sponsor and when to bill insurance, how to reduce billing risk, how to speed delivery of novel therapies such as CAR T cells, and how to streamline budget development with clinical operations and revenue cycle teams.
Why attend: Clinical research billing errors create compliance risk for sites and sponsors. This session shares leading practices for using technology to build a compliant billing program. It suits compliance staff at academic medical centers and health systems, clinical study coordinators, research nurses, research finance and patient billing staff, and pharmaceutical companies.
What’s covered
- Optimal setup of electronic health records
- Using technology to build compliance
- Best practices in clinical research billing
- Handling clinical trials that require inpatient stays
- Downstream impacts of optimizing the EHR for research billing
- Streamlining budget development for clinical trials
- Working with clinical operations and revenue cycle staff
Who should attend
What you get
About the speaker
Mary Veazie is a CPA and seasoned clinical research finance expert with more than 20 years of experience serving as the interface between principal investigators, clinical operations, and executive leaders in order to drive the development and implementation of clinical research program initiatives. Over the course of her career, she has been an innovative healthcare leader with a unique perspective in managing the financial aspects of the clinical research enterprise. She brings extensive experience in financial program management, financial modeling, and business plan development within the clinical trial space. Mary has a strong understanding of federal and FDA regulations governing the life sciences industry which has made her successful at leading initiatives and business transformation projects.

